Issue Contents:  Jan 20, 2009

• Peptimmune, Novartis Sign $500M Deal for MS Drug
• Drop in Manufacturing Demand Prompts Cuts to XOMA's Staff
• Will Health Care Reform Save Biotech, Economy
• NewCo News: Carolus Therapeutics Wants to be King of Cytokine Targeting
• Holiday Notice
• Corrections & Clarifications
• FDA Issues Final Guidance on Rules for GE Animals
• Clinic Roundup
• Other News To Note

      The above issue is also available as one PDF File